(Q40887292)

24 September 2017

Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients (English)

1 reference

24 September 2017

1 reference

7

Larsson R

1 reference

24 September 2017

8

Nygren P

1 reference

24 September 2017

Dhar S

1

1 reference

24 September 2017

Gullbo J

2

1 reference

24 September 2017

Csoka K

3

1 reference

24 September 2017

Eriksson E

4

1 reference

24 September 2017

Nilsson K

5

1 reference

24 September 2017

Nickel P

6

1 reference

24 September 2017

language of work or name

1 reference

1 April 2000

1 reference

European Journal of Cancer

24 September 2017

1 reference

24 September 2017

36

1 reference

24 September 2017

6

1 reference

24 September 2017

803-809

1 reference

A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Effect of suramin on human esophageal cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Suramin: an anticancer drug with unique biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Antiangiogenic and antiproliferative activity of suramin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Redundancy of autocrine loops in human osteosarcoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Verapamil and cyclosporin A sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Effect of prior cancer chemotherapy on human tumor-specific cytotoxicity in vitro in response to immunopotentiating biologic response modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Inhibition of human immunodeficiency virus type I reverse transcriptase by suramin-related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

New sulfonated distamycin A derivatives with bFGF complexing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Suramin stimulates B-lymphocyte proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

Effects of suramin on human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900024-1

7 January 2021

10.1016/S0959-8049(00)00024-1

Identifiers

DOI

1 reference

24 September 2017

1 reference